02 / Our capabilities
Regulatory & Institutional Access
Regulatory approval, institutional access and commercial procurement are related but distinct pathways. Requirements differ by product category, intended use and route to market.

Regulatory and institutional access roadmap
An example of how to plan access for a medical device in Mexico.
Define the product
Document the intended use, product characteristics and planned distribution model.
Potential outputBasis for classification and review of the registration pathway
Review the regulatory pathway
Identify requirements and potential procedures for the product category.
Potential outputOverview of requirements and open questions
Prepare the dossier
Review technical, clinical and administrative documentation and identify gaps.
Potential outputDossier checklist with responsibilities
Plan institutional access
Review purchasing channels and additional requirements at target institutions.
Potential outputPlan for the next steps with target institutions
The challenge
Regulatory approval, institutional access and commercial procurement are related but distinct pathways. Requirements differ by product category, intended use and route to market.
How CRMevidence could support
Map applicable regulatory and documentation workstreams, including relevant COFEPRIS processes; identify institutional stakeholders and purchasing pathways; coordinate questions for authorised regulatory specialists; assess evidence and product-information readiness.
Potential project outputs
A regulatory and institutional stakeholder map, documentation gap list, responsibility matrix and phased action plan for local market access.
Important qualification
No approval, registration or inclusion in an institutional catalogue is guaranteed. Product-specific legal and regulatory conclusions must be confirmed by authorised professionals.
Additional detail from CRMevidence corporate profile (November 2026)
The CRMevidence corporate profile describes medical-device classification, COFEPRIS registration strategy, dossier preparation, establishment compliance, distribution controls and post-market obligations. It distinguishes regulatory authorisation from institutional inclusion and purchasing decisions.
Proposed service scope. Subject to confirmation by CRMevidence.